STK17A and cervical carcinoma: The level of increased PTX resistance of DRAK1-depleted HeLa cells was similar to that of HeLa/PTX cells, suggesting that DRAK1 expression is associated with paclitaxel chemoresistance in cervical cancer cells (Fig. 1D).